JiangSu HongHui Medical CO.,LTD.

About Honghui JIANGSU HONGHUI PHARMACEUTICAL CO.,LTD. was established in Feb. 1998. Before its establishment Honghui was the New Drugs Department Agency of Jiangsu Medical Co., Ltd., a state-owned enterprise. Now Honghui has developed into an integrated company dealing with research & development, production, distribution and marketing.         Our R&D department collaborates with domestic leading institutes with focus on innovative new drugs with a bright future; Jiangsu Shenlong Pharmaceutical Co., Ltd., our subsidiary company with a GMP certificate, is in the position to supply more than 100 products in different specifications and dosage forms such as Infusion solutions, Injections, Capsules, Tablets, Granules, Pharmaceutical Intermediates & Raw materials and so on.         Concerning marketing, we attach same importance to vicegerent products and our own drugs. The best selling product lines are as below: Cardiovascular products Oncological products Orthopedic product Gynecological products         Our sales network has a service covering all through the country; meanwhile, we have established long-term consigned relations with 4 pharmaceutical giants in China.         Honghui has been enjoying rapid expansion since its establishment. We are extending international commerce and are glad to cooperate with foreign enterprises. We would be glad to be your reliable partner in China. Economic function 　　  distribution of drugs   　　- research & development 　　 - production & manufacture Headquarter: 　　Nanjing City , Jiangsu Province, China Three distribution companies in two provinces 　　- East China/ two in Jiangsu Province (73 million people) 　　- South China / one in Hainan Province Honghui’s areas of distribution Distribution for fifteen important Chinese companies, and their twenty-two products Total provinces in China:         29 Coverage by Honghui:           28 Jiangsu Province: Own sales force   Other provinces: Distribution by qualified/powerful sales agents   Specialized according to indicated areas Jiangsu Chengchuang New Drug R&D Co., Ltd is a subsidiary of JiangsuHonghui Pharmaceutical Co.,Ltd.Its high-educated professional R&Dteam devoted themselves to innovate chemical medicine, Biochemical drug, natural extract medicine and traditional Chinese prescription. Chengchuang located in Nanjing, enjoying in longstanding cooperation with famous demestic medicine R&D institutes such as China medicine university, Shandong Institute of Material Medicaand so on… Through great effort,our unique product Complex Peptide Injection and Complex Peptide Tablet have made great success in China market,and the later one—Eifen(Etamsylate) also launched in to China in 2004. Now some anti-cancer products have past clinic trial and will come into market soon. Besides this, many new products such as hepatic drugs, gynaecologic drugs are under development. We are glad to bring bright future to humanbeing by qualified high-tech products.